drugset / Trial / NCT04737408
Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study)
RandomizedParallel-groupOpen-labelPrevention
Summary
The FLOW-PROMOTE Study is an investigator-initiated, Danish multicenter study of patients with stable chest pain investigating whether lipid lowering is associated with recovery of impaired coronary flow as assessed by CT derived fractional flow reserve (FFRCT).
Timeline
- Start
- 2020-05-13
- Primary completion
- 2023-08
- Completion
- 2023-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosuvastatin | Small molecule | 40 mg | — |